Related Experiment Video
Updated: Apr 24, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Inherited cardiomyopathies
1The Heart Institute, Cincinnati Children's Hospital Medical Center.
Insights
Genetic cardiomyopathies, diseases of the heart muscle, involve specific protein pathways. Understanding these genetic causes is key to explaining variable disease phenotypes and outcomes.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies are leading causes of heart muscle disease, morbidity, and mortality.
- A significant portion of cardiomyopathies are genetic and inheritable.
- Recent decades have seen major advancements in discovering the genetic underpinnings of these disorders.
Purpose of the Study:
- To describe the genetics and underlying mechanisms of various cardiomyopathies.
- To elucidate the 'final common pathway' concept in cardiomyopathy pathogenesis.
- To explain the genetic basis of Left Ventricular Noncompaction Cardiomyopathy (LVNC) as an overlap disorder.
Main Methods:
- Review of genetic discoveries in cardiomyopathies over the past two decades.
- Analysis of protein pathways implicated in different cardiomyopathy classifications.
- Examination of genetic factors contributing to phenotypic variability in cardiomyopathies.
Main Results:
- Mutated genes in cardiomyopathies often encode proteins forming a 'final common pathway'.
- Specific pathways identified include sarcomere (hypertrophic, restrictive), sarcomere-sarcolemma linkage (dilated), and desmosome (arrhythmogenic).
- LVNC involves overlap, potentially engaging any of these pathways depending on the specific form.
Conclusions:
- Genetic mutations converge on specific protein pathways, defining cardiomyopathy types.
- Phenotypic variability in cardiomyopathies stems from factors yet to be fully understood.
- Understanding these genetic pathways is crucial for diagnosing and potentially treating cardiomyopathies, including LVNC.
Abstract:
Cardiomyopathies (ie, diseases of the heart muscle) are major causes of morbidity and mortality. A significant percentage of patients with cardiomyopathies have genetic-based, inheritable disease and, over the past 2 decades the genetic causes of these disorders have been increasingly discovered. The genes causing these disorders when they are mutated appear to encode proteins that frame a "final common pathway" for that specific disorder, but the specifics of the phenotype, including age of onset, severity, and outcome is variable for reasons not yet understood. The "final common pathways" for the classified forms of cardiomyopathy include the sarcomere in the primarily diastolic dysfunction disorders hypertrophic cardiomyopathy and restrictive cardiomyopathy, the linkage of the sarcomere and sarcolemma in the systolic dysfunction disorder dilated cardiomyopathy, and the desmosome in arrhythmogenic cardiomyopathy. Left ventricular noncompaction cardiomyopathy (LVNC) is an overlap disorder and it appears that any of these "final common pathways" can be involved depending on the specific form of LVNC. The genetics and mechanisms responsible for these clinical phenotypes will be described.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:29Cardiomyopathy VI: Nursing Management